Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines

被引:43
作者
Passiglia, F. [1 ]
Pilotto, S. [2 ]
Facchinetti, F. [3 ]
Bertolaccini, L. [4 ]
Del Re, M. [5 ]
Ferrara, R. [6 ]
Franchina, T. [7 ]
Malapelle, U. [8 ]
Menis, J. [9 ]
Passaro, A. [10 ]
Ramella, S. [11 ]
Rossi, G. [12 ,13 ]
Trisolini, R. [14 ]
Novello, S. [1 ]
机构
[1] Univ Turin, San Luigi Hosp, Dept Oncol, Reg Gonzole 10, I-10043 Orbassano, TO, Italy
[2] Univ Verona, Azienda Osped Univ Integrata, UOC Oncol, Verona, Italy
[3] Univ Paris Saclay, INSERM U981, Gustave Roussy Canc Campus, Villejuif, France
[4] European Inst Oncol IRCCS, Div Thorac Surg, IEO, Milan, Italy
[5] Univ Hosp Pisa, Dept Clin & Expt Med, Unit Clin Pharmacol & Pharmacogenet, Pisa, Italy
[6] Fdn IRCCS Ist Nazl Tumori, Med Oncol, Milan, Italy
[7] Univ Messina, Dept Human Pathol G Barresi, Messina, Italy
[8] Univ Naples Federico II, Dept Publ Hlth, Naples, Italy
[9] Univ Padua, Dept Surg Oncol & Gastroenterol, Med Oncol Dept, Ist Oncol Veneto IRCCS, Padua, Italy
[10] European Inst Oncol IRCCS, Div Thorac Oncol, IEO, Milan, Italy
[11] Campus Biomed Univ, Radiotherapy Unit, Rome, Italy
[12] S Maria delle Croci Hosp Ravenna, Azienda USL Romagna, Pathol Anat, Ravenna, RA, Italy
[13] Degli Infermi Hosp Rimini, Rimini, Italy
[14] St Orsola Marcello Malpighi Hosp, Intervent Pulmonol Unit, Bologna, Italy
关键词
Non-small cell lung cancer; Metastatic disease; Clinical practice guidelines; Recommendations; TYROSINE KINASE INHIBITORS; PLATINUM-BASED CHEMOTHERAPY; ANAPLASTIC LYMPHOMA KINASE; CISPLATIN PLUS GEMCITABINE; FACTOR RECEPTOR MUTATIONS; UNCOMMON EGFR MUTATIONS; PHASE-III TRIAL; OPEN-LABEL; 1ST-LINE TREATMENT; SINGLE-ARM;
D O I
10.1016/j.critrevonc.2019.102858
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Italian Association of Medical Oncology (AIOM) has developed clinical practice guidelines for the treatment of patients with advanced non-small cell lung cancer (NSCLC). In the current paper a panel of AIOM experts in the field of thoracic malignancies discussed the available scientific evidences, with the final aim of providing a summary of clinical recommendations, which may guide physicians in their current practice.
引用
收藏
页数:11
相关论文
共 146 条
[1]  
[Anonymous], N ENGL J MED
[2]  
[Anonymous], J CLIN ONCOL
[3]  
[Anonymous], WORLD C LUNG CANC
[4]  
[Anonymous], N ENGL J MED
[5]  
[Anonymous], RACCOMANDAZIONI 2019
[6]  
[Anonymous], 2018, CANCERS BASEL
[7]  
[Anonymous], LANCET ONCOL
[8]  
[Anonymous], 2019 WORLD C LUNG CA
[9]  
[Anonymous], 2019, J CLIN ONCOL S
[10]  
[Anonymous], CLIN LUNG CANC